Shares of ClearPoint Neuro Inc. (CLPT) touched a new 52-week high of $10.84 yesterday, driven by recent strong quarterly results and an upgraded annual forecast, which has captured investors' attention.
ClearPoint Neuro is a global device, cell, and gene therapy-enabling company comprised of two parts: (i) a business providing medical devices for neurosurgical applications, and (ii) a business focused on partnerships in the biologics and drug delivery space.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.